More serious, though much rarer, risks have been identified, including a potential increased risk of pancreatitis and gallbladder problems
Contributing Researchers Recognized for published work that shaped the scientific context discussed above Jesper Lau, PhD led the discovery and medicinal-chemistry work describing the once-weekly GLP-1 analogue semaglutide ( Journal of Medicinal Chemistry , 2015) [2]
Patients with specific genetic variants may achieve better results at lower doses or require adjusted titration schedules
A 23-year-old woman with migraines for three months, who did not respond to musculoskeletal or pharmaceutical therapies, was given a multivitamin, magnesium oxide, and Ulmus rubra
Women should seek urgent medical attention for severe abdominal pain suggesting pancreatitis and maintain regular GLP-1 therapy monitoring appointments